| Dr Peter E Jensen, MD | |
|
7410 S Creek Rd Ste 104, Sandy, UT 84093-6151 | |
| (801) 501-8346 | |
| (801) 501-2627 |
| Full Name | Dr Peter E Jensen |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 34 Years |
| Location | 7410 S Creek Rd Ste 104, Sandy, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033215686 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 188598-1205 (Utah) | Primary |
| Entity Name | Utah Vein Specialists, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720269558 PECOS PAC ID: 0749366144 Enrollment ID: O20080326000256 |
News Archive
Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.
Nearly one-quarter of privately insured colon surgery patients are readmitted to the hospital within three months of discharge at a cost of roughly $9,000 per readmission, according to Johns Hopkins researchers, who've identified a major area for quality improvement and cost reduction in health care.
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
According to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, caffeine use prevents increased risk taking that occurs after several nights of total sleep deprivation.
Research published in The Lancet shows that the PHiD-CV10 vaccine is highly effective at protecting children against invasive pneumococcal disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter E Jensen, MD 7410 S Creek Rd Ste 104, Sandy, UT 84093-6151 Ph: (801) 501-8346 | Dr Peter E Jensen, MD 7410 S Creek Rd Ste 104, Sandy, UT 84093-6151 Ph: (801) 501-8346 |
News Archive
Pharmacyclics, Inc. today announced that new pre-clinical and clinical data for ibrutinib (IMBRUVICA) will be highlighted at the 2015 American Association for Cancer Research Annual Meeting to be held April 18 – 22, 2015, in Philadelphia, PA.
Nearly one-quarter of privately insured colon surgery patients are readmitted to the hospital within three months of discharge at a cost of roughly $9,000 per readmission, according to Johns Hopkins researchers, who've identified a major area for quality improvement and cost reduction in health care.
Shire plc, the global specialty biopharmaceutical company, today presented positive data from a Phase III clinical trial (TKT-034) designed to evaluate the safety of switching to VPRIV (velaglucerase alfa for injection), from imiglucerase, as well as an interim analysis of safety data from an ongoing multicenter open-label treatment protocol (HGT-GCB-058) implemented to provide VPRIV to patients affected by the continuing shortage of imiglucerase.
According to a research abstract that will be presented on Wednesday, June 10, at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, caffeine use prevents increased risk taking that occurs after several nights of total sleep deprivation.
Research published in The Lancet shows that the PHiD-CV10 vaccine is highly effective at protecting children against invasive pneumococcal disease.
› Verified 2 days ago
Stephen E. Morris, MD Surgery Medicare: Medicare Enrolled Practice Location: 7631 S Mary Esther Cir, Sandy, UT 84093 Phone: 801-574-1600 | |
Matthew Jason Hancey, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9500 S 1300 E, Sandy, UT 84094 Phone: 801-501-2555 | |
Dr. O Layton Alldredge, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 9720 South 1300 East, W110, Sandy, UT 84094 Phone: 801-571-9511 Fax: 801-571-9823 | |
John M Thueson, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 9660 S 1300 E, Sandy, UT 84094 Phone: 801-993-9532 Fax: 801-733-5872 | |
Christian Layne Sybrowsky, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 9844 S-1300e, #100, Sandy, UT 84094 Phone: 801-571-9433 Fax: 801-572-5607 | |
Dr. David N. Clayton, M.D., F.A.C.S. Surgery Medicare: Not Enrolled in Medicare Practice Location: 9450 S 1300 E, Suite 220, Sandy, UT 84094 Phone: 801-501-6250 Fax: 801-501-6260 |